Taxanes
Cabazitaxel
The FDA lists this product in 11 strengths and forms.
Composition
- Active ingredients
- CABAZITAXEL 60MG/1.5ML (40MG/ML)
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CABAZITAXEL 60MG/1.5ML (40MG/ML) · SolutionThis page
- CABAZITAXEL UNKNOWN · UnknownANDA207735-001 · Tentative approval
- CABAZITAXEL 60MG/6ML (10MG/ML) · SolutionNDA207970-001 · Discontinued
- CABAZITAXEL 60MG/1.5ML (40MG/ML) · SolutionANDA207693-001 · Prescription
- CABAZITAXEL 20MG/ML · InjectableNDA207937-001 · Tentative approval
- CABAZITAXEL 60MG/1.5ML (40MG/ML) · SolutionANDA207718-001 · Prescription
- CABAZITAXEL 60MG/1.5ML (40MG/ML) · SolutionANDA207736-001 · Discontinued
- CABAZITAXEL 60MG/6ML (10MG/ML) · SolutionNDA208715-002 · Tentative approval
- CABAZITAXEL 45MG/4.5ML (10MG/ML) · SolutionNDA208715-001 · Tentative approval
- CABAZITAXEL 60MG/1.5ML (40MG/ML) · SolutionANDA207381-001 · Discontinued
- CABAZITAXEL 60MG/3ML (20MG/ML) · SolutionNDA207949-001 · Discontinued
Official product information
At a glance
- Brand name
- Cabazitaxel
- Drug class
- Taxanes
- Route
- Intravenous
- Dosage form
- Solution
- Applicant
- Breckenridge
- Status
- Discontinued
- FDA approval
- 23 Jun 2022
- Application
- ANDA207619-001
- RxCUI
- 996051



